He's been consulting to the ACW since Dec 2020, so he knows the company well, and they know him and his management style. Also he invested at 0.22 in Feb 2021. He helped PB with 4 fund raises and a listing on the NASDAQ before leaving in October 2018. He's currently the Clinical Pharmacology at University of California, San Francisco. Interesting mix of academic (Uni of California) and fund raising skills. Seems as if he fits what ACW currently needs. Question is after wearing comfy slippers at Uni, does he have the drive? TWT.
He's been consulting to the ACW since Dec 2020, so he knows the...
-
- There are more pages in this discussion • 119 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
